rss
J Clin Pathol 2005;58:322-324 doi:10.1136/jcp.2004.019299
  • Short reports/Case reports

Immunohistochemical assays in prostatic biopsies processed in Bouin’s fixative

  1. V Ananthanarayanan1,
  2. M R Pins2,
  3. R E Meyer3,
  4. P H Gann1,4
  1. 1The Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
  2. 2The Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611
  3. 3The Pathology Core Facility, Northwestern University Feinberg School of Medicine
  4. 4Department of Preventive Medicine, Robert H Lurie Comprehensive Cancer Center, Chicago, IL 60611, USA
  1. Correspondence to:
 Dr V Ananthanarayanan
 Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, 680 North Lake Shore Drive, Suite1102, Chicago, IL 60611, USA; vijunorthwestern.edu
  • Accepted 24 August 2004

Abstract

Aims: To investigate the problems involved in undertaking immunohistochemistry (IHC) and nuclear morphometry using Bouin’s fixed prostate biopsies.

Methods: Archival Bouin’s fixed and formalin fixed, paraffin wax embedded prostatic biopsies were immunostained for three nuclear biomarkers (minichromosome maintenance protein 2 (MCM-2), p27, and Ki-67), one membrane localised biomarker (C-erb-B2), CD34, and α methylacyl-CoA racemase (AMACR). The quality of IHC staining was compared between tissues prepared separately in both fixatives. Feulgen staining was also performed on Bouin’s fixed tissues to check its suitability for nuclear morphometry.

Results: MCM-2 staining was completely negative in Bouin’s fixed tissues, whereas p27 showed more background and excess cytoplasmic staining in Bouin’s fixed versus formalin fixed tissues. C-erb-B2 showed non-specific, strong luminal cell staining in the Bouin’s fixed tissue. Feulgen staining was also very weak in Bouin’s fixed tissue. However, Ki-67, AMACR, and CD34 worked equally well in Bouin’s and formalin fixed tissues.

Conclusions: Bouin’s fixed tissues may be unsuitable when subsequent IHC and morphometry are contemplated. An awareness of which antibodies are suitable for use in Bouin’s fixed biopsies is essential.

Footnotes

    Responses to this article

    Latest from JCP Education

    Latest from JCP Education

    Register for free content


    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
    View free sample issue >>

    Free archive
    The full back archive is now available for JCP. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • Latest Pathology jobs

    Latest Pathology jobs